Wu Ting hadn't even begun his research, yet he was already considering various risk management strategies. Many of the points he raised were the exact pitfalls Lou Musaang and Jia Jun had stumbled into when they were young and inexperienced.
They had only learned these painful lessons by looking back and summarizing their experiences. They never expected this young man to possess such depth and breadth of thought, his considerations both comprehensive and seasoned.
Although neither of them said it aloud, their posture, gaze, and attitude were all slowly changing.
Their interactions with Wu Ting also began to feel more like a mutual resonance, an exchange between equals.
"Phase three is the clinical trial stage. Before a new drug is approved for the market, it must undergo Phase I, II, and III clinical trials. In this stage, the drug is administered directly to humans to evaluate its safety and efficacy..."
